The Global X Japan Bio & Med Tech ETF seeks to invest in Japanese companies positioned to benefit from the increased adoption of biomedical technologies, including companies whose principal business is in biopharmaceuticals, medical equipment, research and outsourced services, and software and electronic platforms, etc.
2639
Global X Japan Bio & Med Tech ETF
FUND SUMMARY
FUND OBJECTIVE
The Global X Japan Bio & Med Tech ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the FactSet Japan Bio & Med Technologies Index.
Why Global X Japan Bio & Med Tech ETF?
High Growth Potential
The Global X Japan Bio & Med Tech ETF enables investors to access high growth potential through companies whose principal business is related to biomedical technologies.
Unconstrained Approach
The Global X Japan Bio & Med Tech ETF's composition transcends classic sectors, industries, and geographic classifications by tracking an emerging theme.
ETF Efficiency
In a single trade, the Global X Japan Bio & Med Tech ETF delivers access to dozens of companies with high exposure to the biomedical technologies theme.
FUND DETAILS As of 12/3/2024
Key Facts
| Securities Code | 2639 |
| ISIN | JP3049310000 |
| Index Ticker | FDSBMTT |
| SEDOL | BNR4PP5 JP |
| Benchmark | FactSet Japan Bio & Med Technologies Index |
| Trading Currency | Japanese Yen |
| Inception Date | 2021/6/21 |
| Record Date | 24th in June and December |
| Trading Unit | 1 |
| NAV per [#] share(s) | 100 |
| Trustee Bank | Sumitomo Mitsui Trust Bank, Limited |
| Exchange | Tokyo Stock Exchange |
|
If the download does not work, please right-click "Open link in new Internet Explorer mode tab" and download again. |
|
Stats & Fees
| Net Assets | ¥461,967,305 |
| NAV | ¥174,574 |
| Management Fee | 0.649％（0.59％ tax excluded） |
Distribution Information
| Latest Distribution | ¥700 |
| Last Closing Date | 6/24/2024 |
| 0.86% |
FUND DOCUMENTS
Indicative NAV (iNAV) As of 12/4/2024
| -- | -- |
| -- | -- |
*Indicative NAV is estimated net asset value (NAV) per share, which is calculated by Solactive AG and provided for reference only.
Estimates are updated during stock exchange trading hours, with a delay of up to 1 minute and 15 seconds from real time.
FUND PRICES As of 12/3/2024
| NAV | ||
|---|---|---|
| Net Asset Value | ¥174,574 | |
| Daily Change | ¥2,376 | 1.38% |
PERFORMANCE HISTORY
Cumulative %Data as of month end (12/3/2024) |
FUND NAV |
|---|---|
| 1 Month | 0.19% |
| 3 Months | 0.00% |
| 6 Months | 7.42% |
| Since Inception | -4.23% |
Distributing Companies (AUTHORIZED PARTICIPANTS)
You can trade at securities companies nationwide. The designated participants are as follows.
Daiwa Securities Co. Ltd.
ABN AMRO Clearing Tokyo Co., Ltd.
Nomura Securities Co.,Ltd.
BNP Paribas Securities (Japan) Limited
Goldman Sachs Japan Co. Ltd.
Mizuho Securities Co., Ltd.
Barclays Securities Japan Limited
TO LARGE INVESTORS
The Application flow for Creation & Redemption is as follows.
| 1ST BUSINESS DAY | 2ND BUSINESS DAY | 3RD BUSINESS DAY | 4TH BUSINESS DAY | 5TH BUSINESS DAY | |
|---|---|---|---|---|---|
| Application for creation | Basket indication | Fixing number of units | |||
| Application period for creation | Acceptance of creation application | Settlement | |||
| Redemption request | Period for Redemption requetst | Acceptance of redemption request | Settlement | ||
| Provisional basket indication | Fixing the basket Fixing number of stocks to be delivered |
The basket will not be indicated in case creation/redemption request acceptance counter is closed.
Basket information
12/06/2024application
12/05/2024application
12/04/2024application
Application/exchange acceptance stop date, application acceptance date for applications with issues subject to financial acceptance
Stocks subject to monetary acceptance are stocks for which money is applied for the amount equivalent to the evaluation value of ex-dividend and ex-rights stocks. Please refer to the basket that we disclose separately for specific brands. Business days that are blank on the calendar are normal application acceptance days.
Global X is a registered trademark of Global X Management Company LLC (hereafter referred to as “Global X LLC”). Any replication, citation, reprinting, transmission or otherwise of Global X – by any means and for any purpose – without permission is prohibited. Global X LLC is a registered investment advisor with the United States Securities and Exchange Commission. The information contained on this website is provided for informational purposes only to the domestic residents in Japan for their securities investment in general and is not intended to solicit any transaction of financial instruments or services. The materials on this website are not the disclosure documents designated by the Financial Instruments and Exchange Act.
All contents of this website are copyrighted by Global X Japan, or by other sources that provided such information. Any replication, citation, reprinting, or transmission of the content – by any means and for any purpose – without permission is prohibited. All the information contained on this website has been obtained from sources believed to be reliable; however, the accuracy and integrity of such information is not guaranteed.
Global X Funds and Global X are the registered trademarks indicating specific exchange-traded funds that Global X LLC is a sponsor or a provider of, or serves as an advisor to around the world, except in Japan. Any replication, citation, reprinting, or transmission – by any means and for any purpose – without permission is prohibited.
Global X Japan Co. Ltd.
Registration No. : Director of Kanto Local Finance Bureau (Financial Instruments Firms) No.3174
Member of Japan Investment Advisers Association
Member of The Investment Trusts Association, Japan